Literature DB >> 19578323

Hemicraniectomy for malignant middle cerebral artery infarction.

Martin Köhrmann1, Stefan Schwab.   

Abstract

PURPOSE OF REVIEW: Space-occupying, malignant hemispheric infarction is one of the most devastating forms of ischemic stroke. Several case series had suggested decompressive hemicraniectomy as a life-saving therapy, but, until recently, there was no proof for this procedure from randomized controlled trials. RECENT
FINDINGS: In 2007, results from a pooled analysis of three European trials as well as data from two of these trials were published and yield compelling evidence for the benefit of hemicraniectomy.
SUMMARY: Data from the published trials leave no doubt about the benefit especially the life-saving character of hemicraniectomy for malignant hemispheric infarction. However, some open questions (i.e. timing of surgery, age limit for hemicraniectomy) remain to be answered in the future.

Entities:  

Mesh:

Year:  2009        PMID: 19578323     DOI: 10.1097/MCC.0b013e328321826e

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  4 in total

1.  Will molecular optical imaging have clinically important roles in stroke management, and how?

Authors:  Dong Kun Lee; Matthias Nahrendorf; Dawid Schellingerhout; Dong-Eog Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

2.  A Cohort Study of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Real-World Experience in Clinical Practice.

Authors:  Zilong Hao; Xueli Chang; Hongqing Zhou; Sen Lin; Ming Liu
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

3.  Long-Term Functionality Prediction for First Time Ischemic Middle Cerebral Artery Stroke Patients Receiving Conventional Medical Treatment.

Authors:  Ju-Lan Yang; Chih-Ming Lin; Ying-Lin Hsu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-02-17       Impact factor: 2.570

4.  Functional Outcome After Decompressive Craniectomy in Patients with Dominant or Non-Dominant Malignant Middle Cerebral Infarcts.

Authors:  Bilal Kamal Alam; Ahmed S Bukhari; Salman Assad; Pir Muhammad Siddique; Haider Ghazanfar; Muhammad Junaid Niaz; Maryam Kundi; Saima Shah; Maimoona Siddiqui
Journal:  Cureus       Date:  2017-01-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.